
Indian Journal of Pharmaceutical Education and Research · Archive
Volumes & Issues
Open a volume to see its issues, then pick an issue for its cover art and complete table of contents.
Keyboard: use Up/Down arrows to move between volumes, Home/End to jump to the first or last, and Enter to open or close a volume.

In this issue
41–45 of 45Original Article(continued)
Smit Jayantilal Patel, Hiralben Mehta, Basheer Ahmmad Shaik, Nadeem Khan
pp. s1310-s1319 · DOI: 10.5530/ijper.20263379 · 2026
Background: Metformin and remogliflozin in fixed dose combination prescribe to control blood sugar and avoid long term complication associated with diabetes mellitus. Aim: The aim is to establish a straightforward and se…
Khagga Bhavya Sri, Tailors Keerthana, Jinkala Pravallika, Mogili Sumakanth
pp. s1320-s1330 · DOI: 10.5530/ijper.20263258 · 2026
Aim: This study develops and validates two analytical methods: An innovative UV-visible chromogenic spectrophotometric method applied to bio-samples and a (RP-HPLC) High-performance liquid chromatography method in revers…
Rishita. D Patel, Harsha V. Patel
pp. s1331-s1340 · DOI: 10.5530/ijper.20263193 · 2026
Objectives: The objective of the pharmacist-led educational Pharmaceutical Care Intervention Program (PLEPCIP) was to evaluate its effect on glycemic control, as measured by HbA1c levels, in patients with type 2 diabetes…
Saptaparni Roy Chowdhury, Jayeeta Majumder, Sourav Gangopadhyay
pp. s1341-s1350 · DOI: 10.5530/ijper.20263391 · 2026
Background: Convenience, accessibility and affordability are the three constructs that is attracting consumers to transform the healthcare landscape digitally into adoption of e-pharmacy. This research study probes into …
Jia Ying Lee, Amira Teoh Binti Mohd Shukri Teoh, Bontha Venkata Subrahmanya Lokesh, Preeti Bala Shrivastava
pp. s1351-s1363 · DOI: 10.5530/ijper.20262387 · 2026
Background: Weak chromophore molecules present challenges in analytical method development for routine quality control testing. This study focuses on three such molecules: favipiravir and molnupiravir, antiviral drugs re…
